Archives

Recent Comments

  • Calvin Yeo { Hi Ameer, yup I agree that SCB trading has been pretty lacking in this aspect. As a guideline though, US charges 30% dividend withholding tax for foreigners, so this is ... } – Jul 15, 12:18 PM
  • Calvin Yeo { Hi David, you can definitely transfer your shares into CDP at a cost, need to check how much it is though. However, I recommend that you at least accumulate a ... } – Jul 15, 12:16 PM
  • Calvin Yeo { Hi minx, you are right about OUE hospitality. In fact, it's a risk which I highlighted before. However, while it is only one property, it is a very well located ... } – Jul 15, 12:09 PM
  • Ameer { Hi Guys Thanks for sharing. I am new to your website and I have started using SCB to buy foreign shares. I am surprised that there is absolutely no info ... } – Jul 09, 3:04 PM
  • David { Hi, I'm currently on BCIP and wish to move a counter into CDP. Do you know if it's possible to move an odd lot into CDP? (eg. 1230 shares in ... } – Jul 05, 7:25 PM
  • minx { Dear Calvin, Thanks for sharing your thoughts on FHT. What is it that you like about OUE hospitality? One thing that held me back from investing is it's concentration risk ... } – Jul 01, 2:10 PM
  • Older »


Olam plunges in price after famous shortist Carson Block questions their accounts

11.21.2012 · Posted in Dividend Stocks, Singapore

This is something which is too interesting not to post about. World renowned shortist Carson Block has made public statements doubting Olam’s accounting methods. The words are indeed very harsh, ranging from comments like “Olam will fail” and recovering for investors will be negligible”. He seems to think that the company will not have anything left for equity shareholders.

This makes for an interesting case study as I take a quick look to see if any of these allegations are true.

There are 3 points made.

1. High leverage

2. Aggressive accounting on biological gains

3. Booking profits on transactions before it is clear how they would work out

Let’s first separate the facts from opinions. 1 and 2 are facts. The 3rd remains an opinion based on public information, unless he knows something which we do not. Although the research firm of Carson Block Muddy Waters has made headlines with uncovering the Sino Forest accounting fraud, not all of its allegations turn out to be 100% factual. The fact that Muddy Waters makes money from shorting the stock can be a conflict of interest for them issuing the report as well.

 

Leverage

 

Current Debt 3,752,127
Long Term Debt 4,614,897
Total Debt 8,367,024
Cash 1,380,244
Net Debt 6,986,780
Equity 3,419,427  3,419,427
 Debt to Equity  Net Debt to Equity
2.45x 2.04x

Olam Sep 30 Debt to Equity Ratio (’000s)

Looking at the Sep 30 balance sheet, Debt to Equity ratio is extremely high at 2.45x while Net Debt to Equity ratio is also extremely high at 2.04x. As a comparison, Noble’s Debt to Equity ratio is 1.11x and Net Debt to Equity ratio is 0.86x. While Noble’s leverage ratios are also high, Olam’s leverage ratio is more than double that of Noble.

 

Current Debt 1,046,983
Long Term Debt 4,679,424
Total Debt 5,726,407
Cash 1,305,603
Net Debt 4,420,804
Equity 5,151,140 5,151,140
 Debt to Equity  Net Debt to Equity
1.11x 0.86x

 Noble Sep 30 Debt to Equity Ratio (’000s)

High leverage ratios are not good for a company as the company may be overextending itself. It also increases the risks of shareholders not getting much left after creditors get their money back. The probability of Olam reducing its leverage is also low as Olam has been running on negative free cash flow for the past 3 years.

Aggressive Accounting on Gains

img olam income statement fy2012

We can see from the above income statement that gains from biological assets are 110,874 in FY2012 which seems to be a small amount compared to revenue but makes up 27% of the profits. Therefore, profits would have been 27% lower if not for the bio gains. In FY 2011, bio gains make up 18% of the profits.

Biological Gains and Booking Profits and Transactions Before They Know How It will Turn Out

Biological gains refer to gains that a company will make over time once a plantation starts producing. They are a valid accounting standard used by agricultural companies. So there is a certain amount of grey area here as the gains are booked ahead of time and no one is sure how these transactions will turn out. Since bio gains is a significant portion of profits, it affects the company dramatically.

So when Muddy Waters refer to booking profits ahead of certainty, are they referring to these bio gains or something else? If it is bio gains, then it is a requirement to understand the accounting standards. If it is something else, then there may be more than meets the eye.

Overall, it is good that there are firms like Muddy Waters who keep a check on public companies to make sure they do not try to defraud public investors, over leverage themselves or whatnots. They may not be a charity, but they are still providing some value in my opinion.

Even if not all Muddy Waters allegations turn out to be true, that should put the Olam management on alert so they would be less inclined to try anything funny. Why target Olam and not Noble and Wilmar? From the short analysis above, Olam has almost double the leverage than its peers and bio gains also make up a much larger proportion of its net profits as compared to Noble. I will wait for the Muddy Water research report before commenting any further.

For more information, you may be interested in:

Palm Oil Plantation Stocks Tree Maturity Profiles

Listing of Felda Global Ventures Bhd

My Singapore Stock Portfolio Early September 2012

Leave a Reply


eight − 6 =

Switch to our mobile site